title: Ovulation induction in polycystic ovary syndrome: a review of conservative and new treatment modalities.
abstract: Polycystic ovary syndrome (PCOS) is a complex disorder with heterogeneous clinical and endocrine features. Chronic anovulation and infertility are common and affect about 75% of the patients. Ovulation induction in PCOS patients is a challenge for the physicians who treat these patients. Several different treatment modalities have been proposed to induce ovulation in PCOS, each of which deals with a different clinical or endocrine disorder which is present in these patients. This review presents traditional and new methods for ovulation induction in PCOS patients, the theoretical background, the pros and cons for each treatment and success rate.
authors.affiliation: Department of Obstetrics and Gynecology, Hadassah University Hospital, Jerusalem, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Meirow
authors.forename: N
authors.initials: N
authors.lastname: Laufer
authors.forename: J G
authors.initials: JG
authors.lastname: Schenker
mesh_terms: D002996:Clomiphene / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D006946:Hyperinsulinism / Q000188:drug therapy / Q000209:etiology; D008596:Menotropins / Q000627:therapeutic use; D009765:Obesity / Q000628:therapy; D010062:Ovulation Induction / Q000379:methods*; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000601:surgery
chemical_list: D002996:Clomiphene; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone